{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:00:35Z","timestamp":1790935235899,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/cgt.2013.30","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T10:18:35Z","timestamp":1369995515000},"page":"375-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer"],"prefix":"10.1038","volume":"20","author":[{"given":"S","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,31]]},"reference":[{"key":"BFcgt201330_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ijc.2910520606","volume":"52","author":"E Sakai.","year":"1992","unstructured":"Sakai. E . The p53 tumor suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int J Cancer 1992; 52: 867\u2013872.","journal-title":"Int J Cancer"},{"key":"BFcgt201330_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1368-8375(02)00064-7","volume":"39","author":"Y Yamazaki","year":"2003","unstructured":"Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H et al. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol 2003; 39: 163\u2013169.","journal-title":"Oral Oncol"},{"key":"BFcgt201330_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/10408360490504952","volume":"41","author":"S Seemann","year":"2004","unstructured":"Seemann S, Maurici D, Olivier M, de Fromentel CC, Hainaut P . The tumor suppressor gene TP53: implications for cancer management and therapy. Crit Rev Clin Lab Sci 2004; 41: 551\u2013583.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"BFcgt201330_CR4","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1200\/JCO.1998.16.9.3158","volume":"16","author":"DG Kirsch","year":"1998","unstructured":"Kirsch DG, Kastan MB . Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol 1998; 16: 3158\u20133168.","journal-title":"J Clin Oncol"},{"key":"BFcgt201330_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1200\/JCO.2008.18.9670","volume":"27","author":"JJ Pan","year":"2009","unstructured":"Pan JJ, Zhang SW, Chen CB, Xiao SW, Sun Y, Liu CQ et al. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol 2009; 27: 799\u2013804.","journal-title":"J Clin Oncol"},{"key":"BFcgt201330_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s002800050959","volume":"44","author":"M Gurnani","year":"1999","unstructured":"Gurnani M, Lipari P, Dell J, Shi B, Nielsen LL . Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer. Cancer Chemother Pharmacol 1999; 44: 143\u2013151.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFcgt201330_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/CAD.0b013e32833db1bb","volume":"21","author":"M Yu","year":"2010","unstructured":"Yu M, Chen W, Zhang J . p53 gene therapy for pulmonary metastasis tumor from hepatocellular carcinoma. Anticancer Drugs 2010; 21: 882\u2013884.","journal-title":"Anticancer Drugs"},{"key":"BFcgt201330_CR8","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1200\/JCO.2007.15.6927","volume":"26","author":"V Keedy","year":"2008","unstructured":"Keedy V, Wang W, Schiller J, Chada S, Slovis B, Coffee K et al. Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma. J Clin Oncol 2008; 26: 4166\u20134171.","journal-title":"J Clin Oncol"},{"key":"BFcgt201330_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00432-009-0701-6","volume":"136","author":"ZX Yang","year":"2010","unstructured":"Yang ZX, Wang D, Wang G, Zhang QH, Liu JM, Peng P et al. Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma. J Cancer Res Clin Oncol 2010; 136: 625\u2013630.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFcgt201330_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/CAD.0b013e32832a2df9","volume":"20","author":"G Tian","year":"2009","unstructured":"Tian G, Liu J, Zhou JS, Chen W . Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial. Anticancer Drugs 2009; 20: 389\u2013395.","journal-title":"Anticancer Drugs"},{"key":"BFcgt201330_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4317\/medoral.18772","volume":"18","author":"SH Huang","year":"2013","unstructured":"Huang SH, O'Sullivan B . Oral cancer: current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 2013; 18: 233\u2013240.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"BFcgt201330_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43\u201366.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt201330_CR13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/cncr.21340","volume":"104","author":"JA Langendijk","year":"2005","unstructured":"Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR . Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 2005; 104: 1408\u20131417.","journal-title":"Cancer"},{"key":"BFcgt201330_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bjoms.2011.08.014","volume":"50","author":"JS Brown","year":"2012","unstructured":"Brown JS, Shaw RJ, Bekiroglu F, Rogers SN . Systematic review of the current evidence in the use of postoperative radiotherapy for oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2012; 50: 481\u2013489.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"BFcgt201330_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.oraloncology.2009.10.011","volume":"46","author":"TY Huang","year":"2010","unstructured":"Huang TY, Hsu LP, Wen YH, Huang TT, Chou YF, Lee CF et al. Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol 2010; 46: 49\u201355.","journal-title":"Oral Oncol"},{"key":"BFcgt201330_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijrobp.2007.10.015","volume":"71","author":"CT Liao","year":"2008","unstructured":"Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion? Int J Radiat Oncol Biol Phys 2008; 71: 371\u2013376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFcgt201330_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3322\/canjclin.55.4.242","volume":"55","author":"GP Snehal","year":"2005","unstructured":"Snehal GP, Jatin PS . TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005; 55: 242\u2013258.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt201330_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00690207","volume":"14","author":"MB Kastan","year":"1995","unstructured":"Kastan MB, Canman CE, Leonard CJ . P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14: 3\u201315.","journal-title":"Cancer Metastasis Rev"},{"key":"BFcgt201330_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1083\/jcb.201009059","volume":"192","author":"PA Muller","year":"2011","unstructured":"Muller PA, Vousden KH, Norman JC . p53 and its mutants in tumor cell migration and invasion. J Cell Biol 2011; 192: 209\u2013218.","journal-title":"J Cell Biol"},{"key":"BFcgt201330_CR20","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1158\/1078-0432.CCR-09-1044","volume":"15","author":"J Nemunaitis","year":"2009","unstructured":"Nemunaitis J, Clayman G, Agarwala SS, Hrushesky W, Wells JR, Moore C et al. Biomarkers Predict p53 gene therapy efficacy in recurrent squamous cell carcinoma of the head and neck. Clin Cancer Res 2009; 15: 7719\u20137725.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201330_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s004410051072","volume":"292","author":"M Weller","year":"1998","unstructured":"Weller M . Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res 1998; 292: 435\u2013445.","journal-title":"Cell Tissue Res"},{"key":"BFcgt201330_CR22","first-page":"1081","volume":"14","author":"H Matsubara","year":"1999","unstructured":"Matsubara H, Kimura M, Sugaya M, Koide Y, Gunji Y, Takegana K et al. Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. Int J Oncol 1999; 14: 1081\u20131085.","journal-title":"Int J Oncol"},{"key":"BFcgt201330_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/CAD.0b013e328345b4e7","volume":"22","author":"X Qi","year":"2011","unstructured":"Qi X, Chang Z, Song J, Gao G, Shen Z . Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Anticancer Drugs 2011; 22: 556\u2013562.","journal-title":"Anticancer Drugs"},{"key":"BFcgt201330_CR24","first-page":"5","volume":"1","author":"WW Zhang","year":"1994","unstructured":"Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA . High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994; 1: 5\u201313.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201330_CR25","first-page":"1715","volume":"5","author":"GL Clayman","year":"1999","unstructured":"Clayman GL, Frank DK, Bruso PA, Goepfert H . Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin Cancer Res 1999; 5: 1715\u20131722.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201330_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/jnci\/91.9.763","volume":"91","author":"SG Swisher","year":"1999","unstructured":"Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 1999; 91: 763\u2013771.","journal-title":"J Natl Cancer Inst"},{"key":"BFcgt201330_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1200\/JCO.2001.19.6.1750","volume":"19","author":"M Schuler","year":"2001","unstructured":"Schuler M, Herrmann R, De Greve JL, Stewart AK, Gatzemeier U, Stewart DJ et al. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 2001; 19: 1750\u20131758.","journal-title":"J Clin Oncol"},{"key":"BFcgt201330_CR28","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1089\/hum.1998.9.14-2075","volume":"9","author":"M Schuler","year":"1998","unstructured":"Schuler M, Rochlitz C, Horowitz JA, Schlegel J, Perruchoud AP, Kommoss F et al. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther 1998; 9: 2075\u20132082.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201330_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2000.18.3.609","volume":"18","author":"J Nemunaitis","year":"2000","unstructured":"Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 2000; 18: 609\u2013622.","journal-title":"J Clin Oncol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201330","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:09:38Z","timestamp":1647950978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,31]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFcgt201330"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2013.30","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,31]]},"assertion":[{"value":"31 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}